GenXPro

GenXPro

Frankfurt, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17.5M

Overview

GenXPro is a privately held, revenue-generating service and platform company based in Frankfurt, Germany, that has been a pioneer in NGS and bioinformatics since 2005. The company's core value proposition lies in its sensitive, low-bias sample preparation kits and full-service offerings, powered by its proprietary TrueQuant UMI technology, which ensures highly accurate quantitative genomics data. It serves diverse markets including academic research, pharmaceutical R&D (particularly in liquid biopsy and precision medicine), and agricultural biotechnology (SMART Breeding). With a strong foundation in molecular biology and bioinformatics, GenXPro is positioned as a specialized provider bridging the gap between complex biological samples and actionable genomic insights.

Genetics & Genomics

Technology Platform

Proprietary NGS sample preparation kits and bioinformatics pipelines, centered on the patented TrueQuant technology which uses Unique Molecular Identifiers (UMIs) to eliminate PCR bias and enable highly accurate quantitative genomics.

Funding History

2
Total raised:$17.5M
Series A$15M
Seed$2.5M

Opportunities

Major growth is driven by the expanding liquid biopsy market for precision oncology, where their sensitive, quantitative TrueQuant technology is a key differentiator.
Additional opportunities exist in agricultural biotechnology (SMART Breeding) and the rapidly growing field of microbiome research, both of which rely heavily on advanced NGS and bioinformatics services.

Risk Factors

The company faces intense competition from large, global life science tools firms and other NGS service providers.
Its reliance on the research-use-only market and cyclical research funding also presents risks, as does the rapid pace of technological change in genomics which could challenge the longevity of current kits and methods.

Competitive Landscape

GenXPro competes in a crowded field of NGS service providers, ranging from large-cap instrument manufacturers (e.g., Illumina, Thermo Fisher) offering services to large CROs (e.g., Eurofins, Charles River) and numerous niche bioinformatics firms. Its primary competitive differentiation is its focus on low-bias, quantitative data from minute samples via its proprietary TrueQuant UMI technology, positioning it as a specialist for demanding applications like liquid biopsy and low-input transcriptomics.